Star Sports Medicine Co., Ltd. (HKG:1609)
Hong Kong · Delayed Price · Currency is HKD 143.80
-0.30 (-0.21%)
Aug 21, 2026, 4:08 PM HKT
Star Sports Medicine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 402.75 | 327.12 | 238.54 | 147.97 | 73.01 | |
Revenue Growth | 23.12% | 37.13% | 61.21% | 102.66% | 176.49% |
Cost of Revenue | 104.13 | 99.52 | 61.23 | 42.66 | 24.36 |
Gross Profit | 298.62 | 227.6 | 177.31 | 105.31 | 48.65 |
Selling, General & Admin | 117.28 | 92.4 | 92.27 | 50.97 | 143.63 |
Research & Development | 47.5 | 37.25 | 35.02 | 18.3 | 21.16 |
Other Operating Expenses | 1.64 | 0.11 | -0.01 | 1.43 | 0.55 |
Operating Expenses | 166.42 | 129.76 | 127.29 | 70.81 | 165.32 |
Operating Income | 132.2 | 97.84 | 50.02 | 34.51 | -116.67 |
Interest Expense | -0.86 | -0.41 | -0.49 | -0.55 | -0.42 |
Interest & Investment Income | 0.52 | 0.06 | - | 3.09 | 1.12 |
Currency Exchange Gain (Loss) | - | - | - | 3.26 | -0.34 |
Other Non Operating Income (Expenses) | 22.31 | 10.08 | 14.79 | -0.03 | -0.02 |
EBT Excluding Unusual Items | 154.17 | 107.57 | 64.32 | 40.27 | -116.34 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.1 |
Asset Writedown | - | - | - | - | -0.03 |
Other Unusual Items | - | - | - | 0.35 | 0.36 |
Pretax Income | 154.17 | 107.57 | 64.32 | 40.63 | -115.91 |
Income Tax Expense | 17.2 | 12.18 | 7.21 | 0.28 | -5.66 |
Net Income | 136.97 | 95.39 | 57.11 | 40.34 | -110.25 |
Net Income to Common | 136.97 | 95.39 | 57.11 | 40.34 | -110.25 |
Net Income Growth | 43.59% | 67.02% | 41.56% | - | - |
Shares Outstanding (Basic) | 46 | 46 | 46 | 62 | - |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 62 | - |
Shares Change | - | 0.09% | -25.06% | - | - |
EPS (Basic) | 2.95 | 2.06 | 1.23 | 0.65 | - |
EPS (Diluted) | 2.95 | 2.06 | 1.23 | 0.65 | - |
EPS Growth | 43.59% | 66.88% | 88.91% | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 122.88 | 67.36 | 62.39 | 47.29 | 4.86 |
Free Cash Flow Per Share | 2.65 | 1.45 | 1.34 | 0.76 | - |
Gross Margin | 74.15% | 69.58% | 74.33% | 71.17% | 66.63% |
Operating Margin | 32.82% | 29.91% | 20.97% | 23.32% | -159.80% |
Profit Margin | 34.01% | 29.16% | 23.94% | 27.27% | -151.00% |
Free Cash Flow Margin | 30.51% | 20.59% | 26.15% | 31.96% | 6.66% |
EBITDA | 143.43 | 108.16 | 59.75 | 36.42 | -115.17 |
EBITDA Margin | 35.61% | 33.07% | 25.05% | 24.61% | -157.74% |
D&A For EBITDA | 11.23 | 10.33 | 9.73 | 1.91 | 1.5 |
EBIT | 132.2 | 97.84 | 50.02 | 34.51 | -116.67 |
EBIT Margin | 32.82% | 29.91% | 20.97% | 23.32% | -159.80% |
Effective Tax Rate | 11.15% | 11.32% | 11.21% | 0.69% | - |